Elpetrigine
Alternative Names: GW293273; JZP-4Latest Information Update: 16 Jul 2016
At a glance
- Originator Jazz Pharmaceuticals
- Developer Jazz Pharmaceuticals plc
- Class Antiepileptic drugs; Pyrazines; Small molecules
- Mechanism of Action Calcium channel antagonists; Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported Bipolar disorders; Epilepsy
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Bipolar-disorders in USA (PO, Controlled release)
- 16 Jul 2016 No recent reports of development identified for phase-I development in Epilepsy in USA (PO, Controlled release)
- 18 Jan 2012 Azur Pharma has merged with Jazz Pharmaceuticals Inc to form Jazz Pharmaceuticals plc